In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Acclarent closes $26mm Series D after pulling IPO

Executive Summary

Following last month's withdrawal of its IPO due to the financial climate, Acclarent (endoscopic surgical devices for chronic sinusitis) looked to venture investors again and raised $26mm through its Series D round. New backer Johnson & Johnson Development Corp. joined returning shareholders New Enterprise Associates, Delphi Ventures, Versant Ventures, and Meritech Capital Partners.
Deal Industry
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

Advertisement
UsernamePublicRestriction

Register